McKesson Corporation

McKesson Corporation is an American healthcare services company that distributes approximately one-third of all pharmaceuticals in North America and operates one of the largest networks of community-based oncology practices in the United States, generating $403 billion in revenue in fiscal 2026. Founded in 1833 as a Manhattan apothecary, the company has evolved through two centuries of healthcare consolidation into a sprawling but increasingly focused platform that touches nearly every node of the pharmaceutical supply chain: wholesale distribution, specialty pharmacy, oncology practice management, biopharma access solutions, and medical-surgical supply.

This is a story about a low-margin distribution giant that is systematically reinvesting its cash flow into higher-value, higher-growth businesses — oncology services, biopharma technology platforms, and specialty drug logistics — while simultaneously returning enormous amounts of capital to shareholders. The file turns on a single question: whether the oncology-and-biopharma-services growth engine can compound fast enough to more than offset the structural margin erosion in the legacy pharmaceutical distribution business that still provides the bulk of revenue and cash flow.

The narrative arc is clearest in the numbers: revenue more than doubled from $198 billion in FY2017 to $403 billion in FY2026, diluted earnings per share rose from $7.23 to $38.38 over the past four years alone, and the company has returned approximately $23 billion to shareholders since the start of fiscal 2020 while still funding bolt-on acquisitions and internal capability build-outs. The market has noticed — McKesson's shares returned over 500% during outgoing CFO Britt Vitalone's tenure — but a sharp sell-off following the Q4 FY2026 earnings report in May 2026, which pushed the stock to the low $700s from over $950 earlier in the year, suggests growing unease about whether the GLP-1 distribution boom, branded-drug price deflation, and the Medical-Surgical separation can all be navigated simultaneously.